After the United Kingdom's referendum vote sent stocks plummeting Friday and Monday, many analysts defended certain names within their coverage universe, claiming share price declines were unwarranted.
Here are the most notable upgrades and reiterations claiming Brexit had overdone its impact on specific companies:
Weyerhaeuser Co WY
DA Davidson upgraded to Buy claiming the company was mainly a domestic unit seeing no significant change in the company’s fundamentals due to Brexit.
Alexion Pharmaceuticals, Inc. ALXN
Citi upgraded to Buy claiming the company was trading below the analyst’s ‘Dark-Sky’ valuation, while it should be approaching $154.00.
American Axle & Manufact. Holdings, Inc. AXL
RBC upgraded to Outperform after noting the company only had 4 percent of its sales exposed to European markets.
Incyte Corporation INCY
Goldman Sachs reiterated Buy, had limited FX exposure, with 89 percent of revenues being generated in the United States.
Newell Brands NWL, Spectrum Brands Holdings, Inc. SPB
The pair looked oversold when Jefferies reviewed stock performance of HPC/beverages relative to Consumer Staples Select Sect. SPDR (ETF) XLP/S&P 500 versus U.K. exposure.
Dynegy Inc. DYN
Citi upgraded to Buy following the ECP buyout and Brexit, thinking it seemed to be excessive.
Evercore Partners Inc. EVR
Buckingham reiterated at Buy, arguing that the company recently witnessed an “outsized” selloff, which “seems overdone.”
Northern Trust Corporation NTRS
Citi upgraded to Neutral arguing the relative decline to the S&P 500 was "a bit overdone with the group now trading at a 11.5 percent average implied cost of equity."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.